World War I
- 1918 flu: vaccine-induced disease caused by extreme body poisoning from the conglomeration of many different vaccines, described as “the greatest medical holocaust in history”.
- Chemical weapons, Largest vaccination campaign in U.S. history…
- Independence of Estonia, Lithuania, Ukraine, Belarus, Poland, Hungary, Czechoslovakia, Austria, Irish Republic, German Revolution, Russian Revolution…
- The Balfour Declaration, League of Nations, Council on Foreign Relations, Royal Air Force, League of Women Voters, League of Red Cross Societies, Code of Canon Law…
- Fiat currency regulations, Banknotes…

World War II
- Nuclear attacks: Atomic Bombs of Hiroshima (Uranium) and Nagasaki (Plutonium).
- Remotely controlled aircrafts, Cluster bombs, Napalm development, Manhattan Project, Large-scale Foot-and-Mouth Disease vaccine production, Biological warfare trials…
- Operation Paperclip (precursor of MK-ULTRA program), New sciences like Cybernetics, Barcode…
- The London Declaration, United Nations, North Atlantic Treaty Organization, Council of Europe, RAND Corporation, Organisation for Economic Co-operation and Development, International Monetary Fund, World Bank, International Trade Organization, International Bank for Reconstruction and Development, General Agreement on Tariffs and Trade, United States Council for International Business, Organization of American States, CIA, State of Israel, Federal Republic of Germany, Constitution of Japan, North & South Korea, Youth for Christ International, World Council of Churches, Apartheid, International Union for the Protection of Nature, Nuremberg Trials, Geneva Conventions, Universal Declaration of Human Rights, Industrial and Commercial Finance Corporation (UK), Finance Corporation for Industry (UK)…
- Bretton Woods system, International monetary system based on convertibility of the various national currencies into U.S. dollar…

Vietnam War
- Approximately 2,756,941 tons of bombs on Cambodia over 5 years.
- Apollo Program, The Phoenix Program, BLU-82B/C-130 weapon system, Concentrated herbicides (20 million gallons), Agent orange (12 million gallons), Anthrax vaccine license…
- Anti-War Movement, Environmental Movement, National Youth Movement, New Age Movement, International Health Regulations, Oil crisis, Comercial Barcode system, Conjugate coding…
- Trilateral Commission, Club of Rome, Nuclear Non-Proliferation Treaty, UN University, UN Environment Programme, UN Development Programme, Outer Space Treaty, African Development Bank, Asian Development Bank, Association of Southeast Asian Nations, Society of Saint Pius X, General Instruction of the Roman Missal, Group of National Associations of Manufacturers of Agrochemical Products, Consultative Group on International Agricultural Research, Finance for Industry (UK), Government Population Panel (UK)…
- Suspended convertibility of U.S. dollar to gold…

Gulf War
- Coalition force from 34 nations with United Nations authorization (“all necessary means to uphold and implement Resolution 660″).
- Gulf War syndrome, Anthrax vaccination, Depleted uranium, Precision-guided munitions, Global Positioning System, Televised war, U.S. policy regarding media freedom much more restrictive than in the Vietnam War…
- UN Conference on Environment and Development, Agenda 21, European Bank for Reconstruction and Development, Oil price shock, Largest oil spill in history, Economic recession, World Wide Web project, Global Environment Facility, Quantum cryptography…
- New World Order announcement, Queen Elizabeth II first British monarch to address United States Congress, Optimum Population Trust, Collapse of the Soviet Union, Foreign Intelligence Service (Russia), New Catechism of the Catholic Church, African Monetary Union…
- Maastricht Treaty, Creation of the euro currency…

War on Terror
- WTC: Nano-thermite.
- Iraq: Invasion without United Nations authorization, Nearly 2,000 tons of depleted uranium bombs.
- Worldwide anti-war protest, the largest protest in human history, The most widely and closely reported war in military history, Quantum computation roadmap…
- Acts, bills, legislation and taxes, Energy and financial crisis, Economic recession, Dramatic increases in world food prices, CropLife International, Inter-American Democratic Charter…
- Euro coins and banknotes enter circulation…

World War III
- Genetically modified, poisoned and radiated food, Water fluoridation, Pandemic viruses and nano vaccines, Mind and body scanners, Electronic surveillance, RFID and nano chips…
- DNA computing and nanotechnology, Genome project, Military cyborgs and drones, State terrorism, HAARP, Chemtrails, Human cloning, Weather manipulation, Asteroids and fake alien invasion…
- Acts, bills, legislation and taxes, Energy and financial crisis, Economic recession, Dramatic increases in world food prices, Martial law, Media, social and academic programming, Corporate fascism…
- New World Order, Global government, Tyranny, Genocide, Depopulation, Enslavement, Mind control, Satanism…
- Global and electronic currency…

Dates

					Balkan Wars
World War I	:		1914-1919	(de jure)	European & Russian Wars
World War II	:	(+20)	1939-1945		Asian & Israel Wars
Vietnam War	:	(+20)	1965-1973	(US Ground war)	African & Afghan Wars
Gulf War	:	(+18)	1991		African & Balkan Wars
War on Terror	:	(+10)	2001-2003	(WTC & Iraq)	Afghan Wars
World War III

About

- Merged with Pfizer in 2009. Financial advisors: Morgan Stanley and Evercore Partners. Legal advisor: Simpson Thacher & Bartlett LLP.
- Wyeth Pharmaceuticals: 37 manufacturing facilities in 17 countries and markets products in over 60 nations.
- Net revenue: $22.8 billion in 2008; $22.4 billion in 2007; $20.4 billion in 2006; $18.8 billion in 2005; $15.9 in 2003; $14.6 in 2002.
- Net income: $4,417.8 million in 2008; $4,810.4 million in 2007; $4,280.8 million in 2006; $3,656.3 million in 2005; $3,258.9 million in 2003; $2,962.6 million in 2002.

2009
- Enbrel (etanercept) is approved for the treatment of chronic severe plaque psoriasis in children aged 8 years and above, making it the only biologic treatment approved for use in children.
- CONBRIZA is approved in the European Union for treatment of postmenopausal osteoporosis in women at increased risk of fracture.
- Chilean Ministry of Health becomes first government agency to approve Prevenar 13 Valent, Pneumococcal Conjugate Vaccine 13 Valent (Diphtheria CRM197 Protein), for infants and young children aged 6 weeks through 5 years.

2008
- Launch of generic version of PROTONIX tablets, in response to the at-risk launch of generic pantoprazole tablets in the U.S. by Teva Pharmaceuticals USA Inc.
- New recombinant XYNTHA available for patients with hemophilia A, a rare, inherited blood-clotting disorder.
- Wyeth and Progenics Pharmaceuticals Inc. receive approval from European Commission and The Therapeutic Goods Administration division of the Australian Government for Relistor for opioid-induced constipation in advanced illness patients. Wyeth has worldwide rights to commercialize all forms of RELISTOR, except in Japan, where Progenics has granted Ono Pharmaceutical Co. Ltd. an exclusive license to the subcutaneous form of RELISTOR for development and commercialization.
- FDA approvals of low-dose regimen of premarin vaginal cream to treat moderate to severe postmenopausal dyspareunia painful sexual intercourse, and TYGACIL, for the treatment of patients with community-acquired pneumonia, and Bazedoxifene, for the treatment of postmenopausal osteoporosis.
- FDA grants Fast Track designation to the investigational 13-valent pneumococcal conjugate vaccine for infants and toddlers. The vaccine includes 6 new serotypes (1, 3, 5, 6A, 7F and 19A) in addition to the 7 serotypes (4, 6B, 9V, 14, 18C, 19F and 23F) included in PREVNAR, Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein), also known as PCV7.
- Fort Dodge Animal Health announces reintroduction of ProHeart 6, a unique heartworm preventative, to the U.S. veterinary market.
- South Africa begins introduction of PREVENAR into childhood immunization program. 27 countries have included PREVENAR in their national immunization programs. PREVENAR, the only licensed pneumococcal conjugate vaccine, is available in 88 countries around the world, with more than 180 million doses distributed.

2007
- The Environmental Protection Agency approves ProMeris for cats and dogs, a low-volume, topical spot-on, to effectively control existing flea and tick infestations and prevent re-infestations on dogs and puppies eight weeks and older.
- Wyeth begins marketing and distributing BeneFIX in Europe.
- FDA approves Lybrel, first low dose combination oral contraceptive offering women the opportunity to be period-free over time; Bazedoxifene, for the prevention of postmenopausal osteoporosis; Protonix (pantoprazole sodium), for delayed-release oral suspension; new dosing recommendations for Rapamune in high immunologic risk renal transplant patients; new BeneFIX features that provide hemophilia B patients a simpler and more convenient preparation process for recombinant factor IX.
- FDA and European Commission approve Torisel for the treatment of advanced kidney cancer.

2006
- Launch of unique spanish-language patient education and support program for EFFEXOR XR depression patients.
- National Agency of Veterinary Medicine (France) temporary approval for Poulvac FluFendTM i H5N3 RG, inactivated virus reverse genetics avian vaccine to aid in prevention of avian influenza caused by H5N1 virus. Fort Dodge developed the vaccine in collaboration with St. Jude Children’s Research Hospital and the University of Wisconsin. The French Ministry of Agriculture and Fisheries requested an initial supply of 7 million doses of this vaccine for use in ducks as part of an avian influenza control program. In several different countries, Fort Dodge‘s products have been supplied as vaccine banks for use in the event of an outbreak. In addition to H5N3 RG, Fort Dodge has approvals for vaccines including H5N9, H5N2, H7N1, H7N2 and H7N3 strains.
- Tygacil (tigecycline), first antibiotic in a new class called glycylcyclines approved in Europe.
- Availability of Advil PM, which combines the multi-pain relieving power of Advil with a gentle sleep aid.

2005
- Wyeth Japan and Takeda Pharmaceutical Company Limited (Takeda Pharmaceutical) announce ENBREL (etanercept) approval by the Japan Ministry of Health, Labour and Welfare for the treatment of rheumatoid arthritis.
- Wyeth and Astellas BV announce European Commission approval of InductOs (recombinant human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge) for the treatment of single level (L4-S1) anterior lumbar spine fusions as a substitute for autogenous bone graft in adults with degenerative disc disease.
- Fort Dodge Animal announces approval of West Nile-Innovator DNA, innovative vaccine for horses to aid in the prevention of viremia caused by the potentially deadly West Nile virus.
- FDA approval of Tygacil (tigecycline), novel I.V. antibiotic indicated for the treatment of complicated skin and intra-abdominal infections in adults, and Effexor XR, for the treatment of panic disorder.

2004
- Widespread availability of the lowest effective dose of Prempro (conjugated estrogens/medroxyprogesterone acetate tablets) 0.3 mg/1.5 mg, that contains 52% less estrogen and 40% less progestin than Prempro 0.625 mg/2.5 mg, and has been shown to be as effective in relieving menopausal symptoms with less breakthrough bleeding and less breast tenderness.
- Fort Dodge Animal Health announces approval of Duramune Adult, first USDA licensed vaccine with 3 year virus challenge data against a trio of deadly canine diseases, canine parvovirus, canine distemper and canine adenovirus.
- FDA approves reformulation of the stomach acid suppressant, Protonix I.V. (pantoprazole sodium) for Injection, first and only proton pump inhibitor in the United States to be offered in both oral and intravenous formulations. The existing Protonix I.V. formulation used clinically for 7 years in more than 5 million patients worldwide.
- FDA approves rhBMP-2/ACS (recombinant human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge), novel protein device that enhances bone healing, for use in the treatment of acute, open tibia shaft fractures in adults.
- Enbrel (25 mg twice weekly) recieves FDA approval for the treatment of adult patients with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy, and European Commission approval for the treatment of adults with severe active ankylosing spondylitis and for monotherapy in the treatment of active rheumatoid arthritis and for use in combination with methotrexate in adults when the response to disease-modifying antirheumatic drugs (including methotrexate unless contraindicated) has been inadequate.
- National advertising campaign, 60-second television commercial and a consumer print advertisement, featuring Prempro (conjugated estrogens/medroxyprogesterone acetate tablets) 0.3 mg/1.5 mg educates women about the appropriate use of hormone therapy and encourages dialogue between women and their health care professionals about the treatment of menopausal symptoms, according to Wyeth Pharmaceuticals.
- FDA grants “fast track” designation for temsirolimus in the first-line treatment of poor-prognosis patients with advanced renal cell carcinoma.
- Enbrel (atanercept) recieves FDA and European Commission approval for the treatment of chronic moderate to severe plaque psoriasis in adult patients. Amgen Inc. and Wyeth Pharmaceuticals announce Enbrel (etanercept) is the first and only biologic to receive an indication by the FDA to induce a Major Clinical Response in patients with rheumatoid arthritis. 50 mg/mL prefilled syringe approved by the FDA as the recommended dosing form for treatment in all approved adult indications.
- FDA approvals of supplemental New Drug Application, for room temperature shipping and storage of PROTONIX I.V. (pantoprazole sodium) for Injection; and ReFacto Antihemophilic Factor (Recombinant) R2 Kit, first needle-less reconstitution device with a prefilled diluent syringe for hemophilia.

2003
- MedImmune Vaccines Inc. and Wyeth Vaccines announce that FluMist (Influenza Virus Vaccine Live, Intranasal), the first influenza vaccine delivered as a nasal mist approved in the United States for healthy people, is available in doctors’ offices and pharmacies nationwide for the influenza season.
- FluMist, Influenza Virus Vaccine Live, Intranasal, incorporated into the influenza vaccine recommendations by the Advisory Committee on Immunization Practices as an option for the vaccination of healthy people aged 5 to 49 years.
- Amgen and Wyeth Pharmaceuticals announce FDA approval of 50 mg once-weekly dosage of Enbrel (etanercept), for adult patients across all indications, including moderately-to-severely active rheumatoid arthritis, active arthritis in patients with psoriatic arthritis and active ankylosing spondylitis, and a 0.8mg/kg once-weekly dosage (maximum 50 mg per week) for patients ages four to 17 years with moderately-to-severely active juvenile rheumatoid arthritis. Instead of taking two 25 mg injections 3 to 4 days apart, can be taken both injections on the same day.
- Protonix I.V. (pantoprazole sodium) for Injection approved by the FDA for intravenous administration over a period of at least 2 minutes, in addition to its current 15 minute infusion regimen. Protonix I.V. is indicated for short-term treatment (7 to 10 days) of patients having gastroesophageal reflux disease with a history of erosive esophagitis, as an alternative to oral therapy in patients who are unable to continue taking PROTONIX Delayed-Release Tablets. Protonix is the first and only proton pump inhibitor in the U.S. to be offered in both oral and intravenous formulations.
- FDA approvals of prescribing information for postmenopausal hormone therapies; Effexor XR (venlafaxine HCI), for the treatment of Social Anxiety Disorder; Ropamune (sirolimus), for a new indication which calls for the withdrawal of cyclosporine from the immunosuppressive regimen; new lower-dose versions of Prempro and Premarin; and CYPHER Stent from the Cordis Corporation, product coated with sirolimus to reduce reblockage in patients recieving stents during coronary procedures.

2002
- Final judicial approval of diet drugs Redux and Pondimin.
- Enbrel (etanercept), first therapy approved by FDA for treatment of psoriatic arthritis.
- FDA approval of Alavert, non-sedating antihistamine, and Advil Allergy Sinus, the first 3 ingredient product containing ibuprofen.
- European Commission marketing authorization of Enbrel (etanercept), for Psoriatic Arthritis, and InductOs (rhBMP-2 on an absorbable collagen sponge), for treatment of open tibial fractures as an adjunct to standard of care.
- Fel-O-Vax FV is launched for the prevention of a serious immunodeficiency disease in cats.

2001
- FDA approval of Effexor XR (venlafaxine HCI) for use in preventing relapse and recurrence of depression.

2000
- Prevnar pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 protein), for the prevention of invasive pneumococcal disease in infants and children, and Protonix (pantoprazole sodium), proton pump inhibitor for the treatment of gastroesophageal reflux disease, are launched.
- Altace (ramipril), sponsored by King Pharmaceuticals Inc. and co-marketed by Wyeth, is the first and only angiotensin-converting-enzyme inhibitor to receive FDA approval for reduction of the risk of stroke, myocardial infarction, and death from cardiovascular diseases in patients 55 or older at high risk of developing a major cardiovascular event.

About

- Merged with Pfizer in 2009. Financial advisors: Morgan Stanley and Evercore Partners. Legal advisor: Simpson Thacher & Bartlett LLP.
- Wyeth Pharmaceuticals: 37 manufacturing facilities in 17 countries and markets products in over 60 nations.
- Deutsche Bank Healthcare Conference (2004, 2006, 2007).
- Goldman Sachs Healthcare Conference (2007, 2008, 2009).
- JP Morgan Healthcare Conference (2005, 2006, 2007, 2008, 2009).
- Citigroup Health Care Conference (2005, 2006, 2007, 2008).
- Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference (2005, 2006, 2007).
- Morgan Stanley Pharmaceutical Unplugged Conference (2005, 2006, 2008).
- Net revenue: $22.8 billion in 2008; $22.4 billion in 2007; $20.4 billion in 2006; $18.8 billion in 2005; $15.9 in 2003; $14.6 in 2002.
- Net income: $4,417.8 million in 2008; $4,810.4 million in 2007; $4,280.8 million in 2006; $3,656.3 million in 2005; $3,258.9 million in 2003; $2,962.6 million in 2002.

1860-1960
- 1860: John Wyeth and his younger brother, Frank, open a retail drugstore with a small research lab in Philadelphia. Both had attended the Philadelphia College of Pharmacy, first school of pharmacy in the U.S. (1822).
- 1862: The Wyeth brothers manufacture medicines in large quantities for doctors and publish their first catalog of drug preparations for wholesale distribution.
- 1864: John Wyeth & Brother supplies medicines and beef extract to the Union Army during the Civil War.
- 1872: Employee Henry Bower develops one of the first rotary compressed tablet machines in the U.S. for mass-producing medicines with unprecedented precision and speed.
- 1876: 4 awards at the U.S. Centennial Exhibition for its compressed pills, pharmaceutical preparations, suppositories, and food for infants and invalids.
- 1883: First foreign facility in Montreal, Canada.
- 1885: Vaccine production begins.
- 1907: John Wyeth dies and his only son Stuart, 1884 Harvard College graduate, becomes President.
- 1926: American Home Products Corporation is founded.
- 1929: Kolynos brand toothpaste becomes a major player in building global sales. Stuart Wyeth dies and leaves controlling interest of John Wyeth & Brother to Harvard University.
- 1930: Anacin (aspirin and caffeine) is purchased and quickly becomes the Company’s leading product. Anacin is also one of the earliest and best examples of concerted television marketing campaign.
- 1931: Harvard sells Wyeth to American Home Products for $2.9 million.
- 1935: Alvin G. Brush, Certified Public Accountant, CEO of the entire organization (1935-1965) launches a diversification and acquisition strategy, acquiring 34 new companies in 15 years, including Chef Boy-Ar-Dee and Wizard Inc.
- 1936: Acquisition of a bacterial antigen for arthritis vaccine research.
- 1938: The S.M.A. Corporation, a pharmaceutical firm specializing in innovative infant formulas, is acquired and folded into John Wyeth & Brother.
- 1941: The United States enters War World II and Wyeth ships sulfa drugs (an early bacteriostatic), blood plasma, typhus vaccine, quinine, and atabrine tablets for malaria to the Armed Forces.
- 1942: Wyeth launches penicillin research program with G. Raymond Rettew, founder of the Chester Country Mushroom Laboratories.
- 1943: Army-Navy E Award for contribution to the war effort. Merger with Ayerst, McKenna and Harrison Ltd. of Canada brings with Premarin, world’s first conjugated estrogens product. 6 companies are merged into Wyeth Laboratories, bringing Tetanus, typhus, diphtheria, smallpox, and sera vaccines, the Tubex method of allergy treatment, a line of antacids and laxatives, a beef extract called Bovinine, and SMA.
- 1944: One of the 22 companies selected by the government to manufacture penicillin, first for the armed forces and then for the general public.
- 1945: Acquisition of Fort Dodge Serum Company.
- 1951: Antabuse is launched for the treatment of alcoholism and the antihistamine Phenergan (promethazine HCI) is introduced.
- 1952: Ansolyen is launched as a high blood pressure medication.
- 1953: Lederle Japan Ltd., 50-50 joint venture between American Cyanamid Company and Takeda Chemical Industries Ltd.
- 1954: Wyeth supplies polio vaccine for critical Salk trials and subsequently becomes a leading U.S. vaccine producer. The anticonvulsant Mysoline is introduced.
- 1955: Headquarters moved from Philadelphia to Radnor, Pennsylvania.
- 1958: Dristan Tablets and the non-narcotic sleeping aid, Sleep-Eze, are launched.
- 1959: Strategic alliance with Rhone-Poulenc for pharmaceutical drug research and development. The labs at Ives Cameron produce Isordil, vasodilator for the treatment of angina.

1961-1999
- 1961: Dryvax, freeze-dried smallpox vaccine, is launched.
- 1966: Oral contraceptive Ovral (norgestrel and ethinyl estradiol tablets), first totally synthetic progestational steroid, is launched.
- 1967: The Global Smallpox Eradication Program is initiated by WHO and approaches Wyeth to develop a better injection system for smallpox to be used in the field. The partnership with Imperial Chemical Industries (Akzo Nobel N.V. subsidiary) pays off with the launch of Inderal, the first beta-blocker for arrhythmia.
- 1968: Patent royalties on innovative new bifurcated needle. Delivery of 200 million smallpox vaccine per year. Ovral becomes the most frequently prescribed oral contraceptive on the market.
- 1970: Wyeth improves infant formula S-26 by developing a physiologic fat blend that closely resembles the fatty acid content of human milk.
- 1975: Lo/Ovral (norgestrel and ethinyl estradiol tablets) is released and becomes the most frequently prescribed low-dose contraceptive in the US.
- 1982: American Home Products acquires Sherwood Medical, capturing a share of the growing medical devices market.
- 1983: Inderal becomes the most frequently prescribed medicine in the US.
- 1984: Whitehall Laboratories markets Advil, first nonprescription ibuprofen in the US and most famous prescrption to over the counter switch in history.
- 1985: Ives Laboratories merges with Wyeth.
- 1987: Wyeth and Ayerst merge into Wyeth-Ayerst Laboratories. The animal health business of Bristol-Myers is acquired and assimilated into Fort Dodge.
- 1988: Acquisition of Parke-Davis animal health business, making Fort Dodge the country’s 3rd largest manufacturer of animal health products. First Haemophilus b conjugate vaccine against bacterial meningitis licensed in the United States for use in infants.
- 1989: Acquisition of A.H. Robins Company, makers of popular consumer brands Robitussin, ChapStick and Dimetapp.
- 1991: The first diphtheria/tetanus/acellular pertussis vaccine in the US and Norplant (levonorgestrel), the first new contraceptive in the US in more than 30 years, are introduced.
- 1992: Building biotechnology capacity, a majority interest in Genetics Institute is acquired. Premarin becomes the number one prescribed drug in the US.
- 1993: The Women’s Health Research Institute is established, the first such pharmaceutical laboratories dedicated entirely to women’s health.
- 1994: Acquisition of American Cyanamid and its subsidiary Lederle Laboratories. Effexor (venlafaxine HCI) is introduced, the first serotonin and norepinephrine reuptake inhibitor for the treatment of depression.
- 1995: Combined sales top $13 billion. Acquisition of the remaining interest in Genetics Institute.
- 1997: BeneFIX Coagulaion Factor IX (Recombinant), novel genetically engineered blood-clotting protein, is introduced for the treatment of hemophilia B. Premarin becomes the first Company product to reach $1 billion in sales. Solvay‘s worldwide animal health business is purchased and folded into Fort Dodge.
- 1998: Enbrel (etanercept), first in class biological treatment for moderate to severe rheumatoid arthritis, is launched by Wyeth and Immunex Corp. (Amgen). Solgar Vitamin and Herb Company is acquired by Whitehall-Robins Healthcare.
- 1999: Meningitec (meningococcal Group C conjugate vaccine) is launched ahead of schedule to help the UK battle an epidemic of meningococcal Group C disease. Rapamune (sirolimus), novel immunosuppresant for kidney transplantation, is launched.

2000
- Cyanamid Agricultural Products is spun-off, marking the final step in the transformation into a research-driven, global pharmaceutical company.
- Collaboration with Elan Corporation to discover, develop and commercialize immunotherapeutic approaches to prevent and treat Alzheimer’s disease.
- Wyeth Pharmaceuticals purchases the Collegeville property from Aventis.

2002
- Designed and tested new animal model in rats to study amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, in a partnership with researchers at leading medical institutions across the United States. The new model is in transgenic rats, which are modified to carry a human gene and develop a neuromuscular disease similar to human amyotrophic lateral sclerosis.
- American Home Products changes its name to Wyeth.
- Wyeth appoints PricewaterhouseCoopers as auditor.
- Immunex Corporation is sold to Amgen.
- Wyeth ceases production of FluShield, injectable influenza virus vaccine, and Pnu-Imune, injectable polysaccharide pneumococcal vaccine for adults, and pursues new flu immunization technologies, specifically through partnership with MedImmune, to develop and market FluMist, an intranasal influenza vaccine.
- FDA approves Wyeth manufacturing site for hemophilia A treatment.

2004
- Wyeth at the Bear Stearns 17th Annual Healthcare Conference, the UBS Global Life Sciences Conference, the CIBC World Markets 15th Annual Healthcare Conference, the Credit Suisse First Boston Healthcare Conference.
- Co-development and co-commercialization agreements with Solvay Pharmaceutical B.V. for bifeprunox and other neuroscience compounds.
- Dissolution of collaboration with MedImmune Inc. for the nasal flu vaccine FluMist (Influenza Virus Vaccine Live, Intranasal) and an investigational second-generation liquid formulation, Cold Adapted Influenza Vaccine-Trivalent. Worldwide rights, manufacturing, marketing, and selling of FluMist by MedImmune Inc., that acquire Wyeth’s distribution facility in Louisville, Kentucky.
- Collaboration with the World Health Organization on clinical trial to investigate the safety and efficacy of moxidectin in onchocerciasis (river blindness) infected individuals. Culmination of an informal 3-year cooperative effort to develop an oral formula for moxidectin and to conduct the pre-clinical analyses and regulatory filings required before initiating a clinical trial in patients.
- 5 oncology researchers who led the development of the first antibody-targeted chemotherapy awarded the Heroes of Chemistry Award from the American Chemical Society.
- Elan Corporation plc and Wyeth Pharmaceuticals announce that the United States Patent and Trademark Office issued Neuralab Limited, subsidiary of Elan, 7 patents for the companies’ joint research on immunotherapeutic approaches to the prevention and treatment of Alzheimer’s disease.
- Manufacturing agreement with Genentech Inc. for Herceptin (Trastuzumab).
- Collaboration with the WHO on a clicnical trial for the study of moxidectin as a possible alternative treatment for onchocerciasis, the world’s second leading infectious cause of blindness.
- Wyeth supports the National Osteoporosis Foundation and the Surgeon General‘s focus on prevention of osteoporosis and promotion of bone health.
- Agreement with an affiliate of PBM Products Inc. for the sale of Georgia, Vermont infant nutrition manufacturing facility.
- The Research & Development Council of New Jersey honors Wyeth Research with the Annual Thomas Alva Edison Patent Award in the “Emerging Technology” category for rapamycin hydroxyesters, a derivative of rapamycin known as temsirolimus (CCI-779). Temsirolimus is an investigational drug, which specifically inhibits mTOR (mammalian target of rapamycin) kinase, an enzyme required to control a cell’s life cycle, preventing cell division into new cells.

2005
- Wyeth at the SG Cowen & Co. 25th Annual Healthcare Conference, the Canadian Imperial Bank of Commerce World Markets’ 16th Annual Heathcare Conference.
- Wyeth purchases additional equity of Wyeth K.K., 70% ownership providing full management control over the joint venture with Takeda Pharmaceutical Company Limited.
- Wyeth opens Grange Castle, one of the world’s largest integrated biotech manufacturing facilities in the South Country Dublin, Ireland.
- Applied Neurotherapeutics Research Group, partnership between Wyeth Neuroscience Research, the Conway Institute at University College Dublin and Trinity College, awarded “Best Partnership Alliance” for its collaborative research approach and its significant contributions to the Irish economy.
- The Chamber of Commerce of Cambridge grants “Leading Edge Award” to the Wyeth Research Campus.
- $32 million contract with National Institutes of Health for ongoing HIV vaccine research.
- Worldwide collaboration with Progenics Pharmaceuticals to develop and commercialize Methylnaltrexone.

2006
- Wyeth at the SG Cowen & Co. 26th Annual Healthcare Conference, the Lehman Brothers 9th Annual Global Healthcare Conference, the Bank of America Health Care Conference.
- Strategic Collaboration with Trubion Pharmaceuticals.
- The American Veterinary Medical Association and Fort Dodge Animal Health announce new educational initiative designed to raise consumer awareness about preventing diseases that can be spread from pets, and other animals, to people, as well as those that can infect both people and pets. These diseases, called zoonotic diseases, include leptospirosis, Lyme disease, rabies, ringworm and giardia.
- Collaboration with the Health Ministry of Scotland to enhance translational medicine research.
- Wyeth purchases an additional 10% stake in Wyeth K.K. bringing Wyeth’s ownership interest in the Wyeth/Takeda Pharmaceutical Company Limited joint venture to 80%.
- Plans with Progenics Pharmaceuticals Inc. for the further development of methylnaltrexone, investigational drug studied as a treatment for the peripheral side effects of opioid analgesics, without interfering with pain relief. In 3 dosage forms: subcutaneous and oral forms as treatment platforms for opioid induced-bowel dysfunction, and an intravenous form for post operative bowel dysfunction.
- Amended and restated co-promotion agreement regarding King Pharmaceuticals‘s product ALTACE (ramipril), an angiotensin converting enzyme inhibitor.

2007
- Wyeth at the Bear Stearns 20th Annual Healthcare Conference, the UBS Global Life Sciences Conference.
- Team of Wyeth scientists involved in the discovery, development and manufacture of PREVNAR, Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein), first and only vaccine available to help protect infants and toddlers against invasive pneumococcal disease caused by vaccine serotypes, awarded the 2005 National Medal of Technology, nation’s highest honor for technological achievement, by President George W. Bush at a White House ceremony.
- New neuroscience discovery, co-development, and co-commercialization agreement with Solvay Pharmaceutical B.V. targeting the identification of small molecules as potential anti-psychotic medications.
- Collaboration with Nautilus Biotech to develop hemophilia therapies.
- Kylin Therapeutics Inc., biotechnology company, signs collaboration with Fort Dodge Animal Health to develop new RNAi therapeutics for the treatment of cancer. Under this contract, Kylin uses its patented RNA nanoparticle technology called “pRNA” to explore the enormous potential of RNA interference (RNAi), and develop new RNA-based therapeutics for the treatment of cancer, Fort Dodge receives an exclusive license to the pRNA/RNAi therapeutic compounds for the treatment of cancers in companion animals and Kylin retains rights to the therapies for human use.
- Research partnership with MediVas to develop advanced hemophilia therapies.
- Wyeth purchases final 20% stake of Wyeth K.K. from Takeda Pharmaceuticals Company Limited.

2008
- Wyeth at the Credit Suisse Healthcare Conference.
- Pristiq (desvenlafaxine), new serotonin-norepinephrine reuptake inhibitor approved to treat adult patients with major depressive disorder, available in U.S.
- Wyeth Consumer Healthcare purchases ThermaCare, a leading over-the-counter heat wrap, from Procter & Gamble.
- Wyeth Pharmaceuticals acquires Thiakis Limited, privately held biotechnology company based in the United Kingdom.

2009
- Strategic alliance with Santaris Pharma to develop RNA-based medicines.
- FDA approves new indication for TYGACIL (tigecycline) for the treatment of adult patients with community-acquired bacterial pneumonia.
- National pneumococcal immunisation programme to vaccinate nearly all Rwandan children younger than one and all Rwandan infants on a routine basis. To help make this program possible in Rwanda and Gambia Wyeth contributed more than 3 million doses of the pneumococcal vaccine through GAVI Alliance. To ensure the sustainable supply of pneumococcal vaccines to countries in the future, GAVI launched a unique financing mechanism known as the Advance Market Commitment (AMC). The governments of Italy, the United Kingdom, Canada, Norway, and Russia, and the Bill & Melinda Gates Foundation launched a pilot AMC against pneumococcal disease with a collective $1.5 billion commitment.
- $100,000 donation to ASCO Cancer Foundation to support cancer prevention and care.
- Exclusive worldwide collaboration with Catalyst Biosciences Inc. for the discovery, development and commercialization of Factor VIIa products to treat hemophilia and other bleeding conditions.
- Wyeth Consumer Healthcare announces availability of new, scientifically advanced, gender-and age-specific adult multivitamin line, Centrum Ultra Women’s and Men’s and Centrum Silver Ultra Women’s and Men’s.
- Worldwide alliance with Ambrx Inc. to discover, develop, and commercialize protein drug candidates for three undisclosed targets in multiple therapeutic areas.
- Pfizer and Wyeth divest certain animal health assets to Boehringer Ingelheim.
- Progenics Pharmaceuticals Inc. regains all worldwide rights to the RELISTOR franchise from Wyeth Pharmaceuticals.

About
- July 2007: Founded.
- July 2008: $29 million in venture finance from several firms, led by Kleiner Perkins Caufield & Byers.
- May 2009: Digital Sky Technologies buys a 1.96% stake of Facebook for $200 million.
- December 2009: Digital Sky Technologies buys $180 million share of Zynga.
- In 5 days (January 2010), more than 300,000 game players purchased $1.5 million in virtual social goods to support relief efforts in Haiti. Users from 47 countries donated to UN World Food Programme by buying limited edition items in FarmVille ($1 million), FishVille, Mafia Wars and Zynga Poker.
- Mission: Connect people through games in a way that is fun and exciting.
- Monthly Active Users: 235 million in February 2010.
- Weekly Active Users: 134 million in February 2010.
- Daily Active Users: 66 million in February 2010; 60 million in December 2009.
- Applications: 39.

FarmVille
- Launch in June 2009.
- Monthly active users: 81 million in February 2010 (1.2% of the World population); 70 million in December 2009; 60 million in October 2009.
- Weekly active users: 54 million in February 2010.
- Daily active users: 31 million in February 2010.
- Game: “Grow delicious fruits and vegetables and raise adorable animals on your very own farm.”
- Level up, coins, features, ribbons, gifts, market and purchasable items.
- 220 million Valentine’s Day gifts exchanged in the first 18 hours since their release.

Mafia Wars
- Available also on MySpace, Tagged, Sonico, and Yahoo!.
- Monthly active users: 25 million in February 2010.
- Weekly active users: 13 million in February 2010.
- Daily active users: 6 million in February 2010.
- Page statistics: 12 million in April 2010.
- Game: “Start a Mafia family with your friends, run 3 kinds of crime businesses, and vie for respect… then fight to be the ruling family.”
- Limited energy, health and stamina meters, level up, bonus, ranks and purchasable items.

Café World
- Monthly active users: 30 million in March 2010.
- Weekly active users: 17 million in March 2010.
- Daily active users: 8 million in March 2010.
- Game: “Choose from dozens of dishes to cook, then slice, chop, saute and bake your way to the top of the culinary world.”

Texas HoldEm Poker
- Monthly active users: 27 million in March 2010.
- Weekly active users: 14 million in March 2010.
- Daily active users: 6 million in March 2010.
- Page statistics: 17 million in April 2010.

FishVille
- 875,000 users within 2 days of launch.
- Monthly active users: 25 million in February 2010.
- Weekly active users: 13 million in February 2010.
- Daily active users: 6 million in February 2010.
- Game: “An addictive game where you raise cute baby fish, feed them as they grow, and decorate your fish tanks with friends.”

PetVille
- Monthly active users: 20 million in March 2010.
- Weekly active users: 11 million in March 2010.
- Daily active users: 5 million in March 2010.
- Game: Choose and care for your own adorable pet, dress, feed, and decorate to make your pet and home the coolest in tow.

YoVille
- Monthly active users: 14 million in February 2010.
- Weekly active users: 6 million in February 2010.
- Daily active users: 2 million in February 2010.
- Game: World where you can buy new clothes for your player, purchase items for your apartment, go to work, and meet new friends.
- Campaign: Selling bulldogs and tabby cats contributed over $90,000 to The San Francisco SPCA (May 2009).

William “Bing” Gordon (1950-)
- Board Member since 2008.
- Partner of Kleiner Perkins Caufield & Byers since 2008.
- Board member of Amazon (2003) and Ngmoco.
- Founding director of Audible.com.
- Executive positions (1982-1993); Senior Vice President Entertainment Production (1992-1993); Executive Vice President of EA Studios (1993-1995); Executive Vice President Marketing (1995-1998); Executive Vice President and Chief Creative Officer (1998-2008) of Electronic Arts.
- Chair position at the University of Southern California‘s Interactive Media Division after Electronic Arts invested in the fledgling program (2005).
- Account Executive of Ogilvy & Mather.
- Graduated from Cranbrook School (1968); Bachelor of Arts from Yale University (1972); Master of Business Administration from Stanford University (1978).

Fred Wilson (1961-)
- Investor.
- Co-founder of Union Square Ventures, $125 million in capital under management.
- Co-founder of Flatiron Partners (1996), fund capitalized at $150 million with investors SOFTBANK Technology Ventures and Chase Capital Partners, private-equity arm of Chase Manhattan Corp, and later another $500 million with Chase Capital Partners as the sole active LP.
- Board member of DonorsChoose.org.
- Bachelors degree in Mechanical Engineering from Massachusetts Institute of Technology and MBA from the Wharton School of the University of Pennsylvania.

Reid Hoffman (1967-)
- Investor and Board of Directors.
- Founder and CEO (2003-2007); Chairman and President Products (2007); Executive chairman of LinkedIn.
- Board director of Mozilla, Burger King, Vendio, Six Apart, Kiva.org, Tagged.
- Investor in Facebook, IronPort, Flickr, Digg, Grockit, Ping.fm, Nanosolar, Care.com, Knewton, Kongregate, Last.fm.
- Member of Provost Council at College Eight, University of California, Santa Cruz.
- Chair of Westcoast Advisory Board at Questbridge.
- Partner at Greylock Partners.
- Co-founder of SocialNet.com.
- Member of the board of directors at the founding; Executive Vice President (2002) of PayPal.
- Member of Oxford Alumni New York, eWorldAlums, PayPal Corporate Alumni, Doctors Without Borders, KIVA, Obama for America, Alpha, Endeavor, The Association of Marshall Scholars Inc., Pre-IPO PayPal employees, Stanford University Alumni, Second Harvest Food Bank of Santa Clara and San Mateo Counties, Dopplr Advisors, Bessemer SaaS CEO Forum, Sequoia Capital Portfolio Company CEOs, Stanford Symbolic Systems Program, Stanford Class of 89, Connecting for Change, LinkedIn Advertising Forum, Friends of LinkedIn, CM Summit NY 2009, European Business Awards, NPR Digital Think, Hemisphere, Surya for Congress, Queen Rania Center for Entrepreneurship.
- Worked at Apple Computer and Fujitsu.
- Attended high school at The Putney School (1982-1985), graduated from Stanford University with bachelor’s degree in symbolic systems (1985-1990) and from Oxford University with a master’s degree in philosophy (1990-1993).

Peter Thiel (1967-)
- Investor.
- President of Clarium Capital.
- Managing partner in The Founders Fund.
- Board of Directors of The Independent Institute, Facebook.
- Donator ($100,000 in 2006) and Advisory board of the Singularity Institute for Artificial Intelligence.
- $3.5 million donation to foster anti-aging research through the Methuselah Mouse Prize Foundation.
- $500,000 donation (2008), $250,000 grant and additional $100,000 in matching funds (2010) to the Seasteading Institute.
- Investor in Facebook ($500,000 in 2004), Slide, LinkedIn, Friendster, Rapleaf, Geni.com, Clickable Inc., Yammer, Yelp Inc., Powerset, Vator, Palantir Technologies, Joyent, IronPort.
- Co-founder and CEO of PayPal (1998), sold to eBay for $1.5 billion (2002).
- Founder of Thiel Capital Management (1996).
- Supporter of the Committee to Protect Journalists.
- Member of Phi Beta Kappa Society, Marijuana Policy Project, Ron Paul 2008 Presidential Campaign Committee, John McCain 2008, Bilderberg Group, DeMint for Senate Committee.
- Former US Education Department Speechwriter for Secy. William Bennett, Law Clerk for US Court of Appeals Judge Larry Edmondson, Securities lawyer at Sullivan & Cromwell, Derivatives trader at Credit Suisse.
- Net worth of $1.3 billion (Forbes 400).
- Honored as Young Global leader by the World Economic Forum (2007), and honorary degree from Universidad Francisco Marroquin (2009).
- At San Mateo High School, California; A.B. Philosophy (1989), founded The Stanford Review (conservative/libertarian newspaper), and J.D. (1992) at Stanford University.

Robert Warren “Bob” Pittman (1953-)
- Investor.
- CEO of MTV Networks, AOL Networks, Six Flags Theme Parks, Quantum Media, Century 21 Real Estate (1995), and Time Warner Enterprises.
- Co-founder of Pilot Group LLC (2003), controlling investments in Thrillist, Barrington Broadcasting, Double O Radio, OTX Research, North American Membership Group, Tasting Table and Vital Juice, Tequila Casa Dragones, and also stakes in David’s Bridal, Spotrunner, iLike.com, Next New Networks, Zynga, Rapleaf, Playlist.com.
- Board of Directors at Playlist.com, Robin Hood Foundation, New York Public Theater, Rock and Roll Hall of Fame, NYU Medical Center, the Alliance for Lupus Research.
- Former board member of Electronic Arts, Atari Games, Excite, 3DO, MTV Networks, America Online, HFS/Cendant/Realogy.
- Former chairman of Robin Hood Foundation, and the New York Public Theater.
- COO and Board of directors of America Online Inc. (1996), where led the operating team that moved from 6 million members to over 30 million, and AOL Time Warner (2001-2002).
- Chairman and CEO of Six Flags Theme Parks (1991).
- President and CEO of Time Warner Enterprises (1990).
- Founder of Quantum Media with MCA Records.
- Oversaw the creation and growth (1st profitable cable network) of MTV and the transition of Nickelodeon from a network geared to preschoolers to one aimed at older kids as well as overseeing the launches of VH-1 and Nick at Nite, and led the initial public offering for MTV Networks and its expansion into international markets.
- Airline Transport Pilot’s license for airplanes, rated for helicopters and 3 types of jets.

Brad Feld
- Investor and Board of Directors.
- Board of directors of Gold Systems, Judy’s Book, NewsGator, Rally Software, StillSecure, the Community Foundation Serving Boulder Country, the Colorado Conservation Trust, Gist, Gnip, Oblong, Standing Cloud.
- Chairman of the National Center for Women & Information Technology.
- Co-founder and Board of Directors of Foundry Group, and Mobius Venture Capital.
- Founder of Intensity Ventures.
- Former Board of Directors of the Young Entrepreneurs Organization.
- Former Chief technology officer of AmeriData Technologies and Feld Technologies after acquisition.
- Bachelor of Science and Master of Science degrees in Management Science from the Massachusetts Institute of Technology.

Sandy Miller
- Investor.
- General partner Institutional Venture Partners since April 2006.
- Board Member of the Stanford Law School and the Cantor Art Center, Stanford University Art Museum.
- Executive Committee of the Capital Campaign of the University of Virginia, where previously College Trustee.
- Former Senior Partner with 3i.
- Co-founder; Executive Committee; Chief Administrative and Strategic Officer; Co-Director of Investment Banking at Thomas Weisel Partners.
- Former Senior Partner at Montgomery Securities, where led the technology group.
- Former Managing Director and opened the San Francisco technology investment banking offices for Merrill Lynch and Donaldson, Lufkin & Jenrette.
- Former Manager of strategy consulting at Bain & Company, and securities lawyer at Pillsbury Winthrop.
- Former Trustee and Board Member of the Stanford Graduate School of Business, the Asian Art Museum of San Francisco, the American Conservatory Theater, and Grace Episcopal Cathedral.
- B.A. from the University of Virginia, Phi Beta Kappa, and M.B.A. and J.D. from Stanford University.

Richard W. Levandov
- Investor.
- Managing Member at Avalon Ventures since 2007.
- Director of Avalon portfolio companies Intercasting Corp. and Chumby Industries as well as Tacoda Systems, Tremor Media, Newsgator Technlogies, Nexaweb, and Liquid Machines Inc.
- Member of the MIT Enterprise Forum, and Masthead Venture Partners.
- Former lead investor and on the boards of Valent Software Corporation (Lycos), Sombasa Media (PrimeMedia), Software.com (OpenWave), Mobilee (Natural MicroSystems), Bright Mail (Symantec) and OLiVER (LivePicture).
- Partner with SOFTBANK Technology Ventures (1996-1998).
- Vice President of Business Development at America Online (1994-1996).
- Co-founder and Vice President of Phoenix Technologies Ltd. (1982-1993).
- B.S. degree from Binghamton University.

About
- 2007: Founded.
- October 2008: $17 million in venture capital funding from Accel Partners and Index Ventures.
- November 2009: Property of Electronic Arts by acquisition for $275 million.
- Playfish Virtual Currency: No monetary value and does not constitute currency or property of any type; Non-refundable; Payment by credit card or billing and payment provider.
- Haiti Donation Page: “If $100,000 in donations (credit card) are made to Mercy Corps, Playfish will give every player in Pet Society, Restaurant City, Country Story and Poker Rivals a special item.” Total raised so far (web): More than $25,000 (March 2010).
- Monthly active users: 50 million in February 2010.
- Weekly active users: 23 million in February 2010.
- Daily active users: 10 million in February 2010.
- Applications: 12.

Pet Society
- Monthly active users: 19 million in February 2010.
- Weekly active users: 10 million in February 2010.
- Daily active users: 4 million in February 2010.
- Game: Custom design pets with activities and interaction including washing, brushing, petting and feeding the pet.
- Level up, coins, features, special status, thriving in-game economy and purchasable items.

Restaurant City
- Monthly active users: 15 million in March 2010.
- Weekly active users: 7 million in March 2010.
- Daily active users: 3 million in March 2010.
- Game: Create and run a restaurant, design it, decorate it, hire friends to work in it, collect ingredients and menu items and visit friends.

Country Story
- Monthly active users: 4 million in March 2010.
- Weekly active users: 2 million in March 2010.
- Daily active users: 1 million in March 2010.
- Game: “Get away from it all in Country Story and forget the stresses of everyday life as you enjoy the tranquil pleasures of your very own country home. Tend your crops and animals, visit friends and breathe in the fresh country air.”

Kristian Segerstrale
- Vice President, General Manager and Co-founder.
- Co-founder and managing director of Europe, Middle East and Asia for Glu Mobile.
- Master’s of science degree in Economics from London School of Economics and undergraduate degree in Economics from Cambridge University.

Sebastien de Halleux
- Chief operating officer and Co-founder.
- Vice President Business Development & Strategic Partnerships at EA Interactive driving distribution, monetization, business development, and relationships with key partners across the division’s 3 business units, Playfish, Pogo and EA Mobile.
- Former part of the team that incubated Nokia Ad Service, and early team member of Macrospace Ltd.
- Master’s in Civil Engineering from Imperial College London.

Sami Lababidi
- Vice President, Chief Technical Officer and Co-founder.
- Co-founder of Macrospace Ltd., a company which merged with Sorrent Inc. to become Glu Mobile.
- Key roles at mobile services firm Digital Mobility and Lehman Brothers.
- Master’s of science in Computer Sciences from Imperial College.

Shukri Shammas
- Senior Director, General and Administrative, Chairman, Chief financial officer and Co-founder.
- Co-founder and managing director of Macrospace Ltd.
- Former Chief technical officer at Internet services provider Domainia, and at the accounting firm Westbury Schotness.
- Bachelor’s in Business Administration from the American College, London.

Privacy Policy
- Account: Information transfer and store in the USA.
- Personal information: Name, email address, phone number, home address, birth date, mobile phone number, credit card information…
- Non-personal information: Gender, zip code, about computer, hardware, software, platform, media, mobile device, mobile device ID, console ID, incident data, Internet Protocol (IP) address, network Media Access Control (MAC) address and connection, feature usage, game play statistics and scores, user rankings and click paths, data provide in surveys (via account preferences and online profiles or through purchases).
- Information from third parties: Personal, non-personal or public information.

About
- 2006: Founded.
- December 2009: Attacker breaches a company database containing the usernames and unencrypted passwords of about 32 million users.
- Mission: Engage the world through social applications.
- Developing also for MySpace, Hi5, Bebo, Friendster, Orkut.
- Investors: Sequoia Capital, First Round Capital, Lightspeed Venture Partners, Partech International, DCM.
- Partners: Creative Artists Agency; Clearspring; Widgetbox; Webs.com (formerly Freewebs); Bebo; Quantcast; Friendster; Flixster; WordPress; Fliptrack; Hi5; Like.com; Nettwerk Music Group; Pump Audio; Tagged.com; SNOCAP; Gigya; Zazzle; Gizmoz; Tapatap; PlayFirst.
- Member of the Alloy Online Advertising Network.
- Monthly active users: 92 million in February 2010.
- Weekly active users: 30 million in February 2010.
- Daily active users: 6 million in February 2010.
- Applications: 17.

Birthday Cards
- Game: “Send your friends the best custom cards, make a custom group birthday card that will be delivered on the special day, manage your birthday calendar, get reminders for your special friends birthdays, and more.”
- Monthly active users: 49 million in February 2010.
- Weekly active users: 14 million in February 2010.
- Daily active users: 2 million in February 2010.

Zoo World
- Game: Build up a zoo, collect and breed animals, hunt for treasure, and trade with friends.
- Monthly active users: 20 million in February 2010.
- Weekly active users: 8 million in February 2010.
- Daily active users: 2 million in February 2010.

Static FBML
- Monthly active users: 58 million in May 2010.
- Weekly active users: 23 million in May 2010.
- Daily active users: 7 million in May 2010.

BlackBerry smartphones
- Monthly active users: 17 million in May 2010.
- Weekly active users: 13 million in May 2010.
- Daily active users: 10 million in May 2010.

iPhone
- Monthly active users: 34 million in May 2010.
- Weekly active users: 25 million in May 2010.
- Daily active users: 17 million in May 2010.